PDE4 News and Research

RSS
Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

EULAR publishes updated recommendations for treating people with psoriatic arthritis

EULAR publishes updated recommendations for treating people with psoriatic arthritis

Resveratrol shows promise for anxiety and depression

Resveratrol shows promise for anxiety and depression

Plant compound found in red wine displays anti-stress effects

Plant compound found in red wine displays anti-stress effects

Scientists develop new class of drugs to treat hereditary kidney disease

Scientists develop new class of drugs to treat hereditary kidney disease

Tetra begins human Phase 1 safety trials of BPN14770

Tetra begins human Phase 1 safety trials of BPN14770

Study reveals potential new therapeutic target for depression treatment

Study reveals potential new therapeutic target for depression treatment

Study explains why COPD patients develop tolerance to roflumilast drug

Study explains why COPD patients develop tolerance to roflumilast drug

Celgene: OTEZLA phase III study for psoriatic arthritis meets primary endpoint

Celgene: OTEZLA phase III study for psoriatic arthritis meets primary endpoint

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Scientists develop new drug to treat obstructive airway diseases

Scientists develop new drug to treat obstructive airway diseases

Celgene International Sàr presents PALACE 3 phase III results of apremilast in psoriatic arthritis at EULAR

Celgene International Sàr presents PALACE 3 phase III results of apremilast in psoriatic arthritis at EULAR

Celgene reports results from placebo-controlled phase II trial in patients with Behçet's disease

Celgene reports results from placebo-controlled phase II trial in patients with Behçet's disease

Apremilast continues to demonstrate meaningful clinical responses in patients with psoriatic arthritis

Apremilast continues to demonstrate meaningful clinical responses in patients with psoriatic arthritis

Celgene announces positive results from first phase III study of apremilast in psoriatic arthritis

Celgene announces positive results from first phase III study of apremilast in psoriatic arthritis

Phase 1b trial validates efficacy of Pulmatrix PUR118 to treat COPD

Phase 1b trial validates efficacy of Pulmatrix PUR118 to treat COPD

Human memory: how to improve yours

Human memory: how to improve yours

PDE4 enzyme regulates division of tumour cells and blood vessel growth in cancer tissue

PDE4 enzyme regulates division of tumour cells and blood vessel growth in cancer tissue

Forest Laboratories second quarter net sales increase 9.0% to $1,130.3 million

Forest Laboratories second quarter net sales increase 9.0% to $1,130.3 million

biocrea and Pfizer jointly presented details on novel PDE10 inhibitors

biocrea and Pfizer jointly presented details on novel PDE10 inhibitors